San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work ...

This revolution is being powered by RNA technology—and Canada is uniquely positioned to lead it. While the swift development ...

With a longtime vaccine skeptic serving as the country’s top health official, the movement is likely to make further inroads.

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

Scientists project that by 2026 the results of clinical trials being conducted in 25 countries, including Spain, will be ...

The potential change outlined in a statement would require all new vaccines to undergo placebo testing, sparking concerns ...

This revolution is being powered by RNA technology — and Canada is uniquely positioned to lead it. While the swift development of COVID-19 vaccines appeared to be a sudden scientific triumph ...